Company intelligence / Profile preview
META Pharmaceuticals
Shenzhen, Guangdong, Chinaen.metabiopharma.com ↗
- Ownership
- Public · META
- Development stage
- Other
01
Overview
META Pharmaceuticals is pioneering the development of first-in-class small molecule drugs targeting immune cell metabolism for autoimmune diseases and metabolic disorders. Its lead program has received FDA Rare Pediatric Disease Designation for primary hyperoxaluria. The company leverages AI-driven target discovery in partnership with Xtalpi and Crystal Jade to identify novel metabolic protease targets. Several programs are in preclinical or IND-enabling stages; no clinical efficacy results have been published yet.
- Therapeutic areas
- Metabolic DisordersImmunologyOtherOncologyRare Diseases
- Modalities
- Small moleculeChemical drugs
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Xtalpi (AI-powered drug design/development partner)Crystal Jade (AI drug development collaboration)
04
Financials
- Market cap
- $1.3T
- Total revenue
- $201B
- Enterprise value
- $1.4T
Beyond the preview
Go deeper on META Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on META Pharmaceuticals.